Overview

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of the artemisinin combination therapy (ACT) in uncomplicated falciparum malaria patients in Myanmar and artemisinin molecular markers analysis
Details
Lead Sponsor:
Department of Medical Research, Lower Myanmar
Collaborator:
Kangwon National University
Treatments:
Antimalarials
Artemether
Artemisinine
Artemisinins
Artenimol
Artesunate
Dihydroartemisinin
Mefloquine
Piperaquine